Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
  1. 4 Open-market sale 10% owner sold 44,722 shares at an average $20.51 ($917,111)
  2. 4 Open-market sale 10% owner sold 44,722 shares at an average $20.51 ($917,111)
  3. 4 Planned sale Chief Financial Officer sold 6,000 shares at an average $19.99 ($119,948)
  4. 4 Planned sale President, Research & Develop. sold 15,891 shares at an average $20.18 ($320,620)
  5. 4 Planned sale President, Research & Develop. sold 4,109 shares at an average $20.03 ($82,300)
  6. 4 Planned sale Chief Financial Officer sold 8,637 shares at $19.98 ($172,562)
  7. 4 Planned sale President, Research & Develop. sold 18,219 shares at an average $18.62 ($339,281)
  8. 4 Planned sale President, Research & Develop. sold 600 shares at $18.00 ($10,800)
  9. 4 Planned sale President & COO sold 847 shares at $16.00 ($13,552)
  10. 4 Planned sale Chief Financial Officer sold 3,195 shares at $14.97 ($47,832)
  11. 4 Planned sale President & COO sold 2,303 shares at an average $15.09 ($34,753)
  12. 4 Planned sale Chief Scientific Officer sold 3,242 shares at an average $15.12 ($49,004)
  13. 4 Shares withheld for taxes CEO gave up 8,722 shares (to pay taxes)
  14. 4 Shares withheld for taxes President & COO gave up 1,808 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,756 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 1,731 shares (to pay taxes)
  17. 4 Planned sale President & COO sold 27,097 shares at an average $16.27 ($440,801)
  18. 4 Planned sale Chief Scientific Officer sold 1,238 shares at $18.00 ($22,284)
  19. 4 Planned sale CEO sold 1,900 shares at an average $17.84 ($33,897)
  20. 4 Planned sale Chief Financial Officer sold 1,758 shares at $14.95 ($26,282)

Page 4 of 13 · 242 filings